71‐1: Quantum Dot Optoelectronics for Biomedical Implants
SID Symposium Digest of Technical Papers · 2026-06 · 57 (1) · 979-982
DOI: 10.1002/sdtp.70001_267 ↗Kurz gefasst
Fachartikel in der Zeitschrift SID Symposium Digest of Technical Papers, online erschienen am 11.09.2026. Verfasst von Sedat Nizamoglu und 11 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Our research presents quantum dot (QD) based optoelectronic platforms that enable precise, minimally invasive near‐infrared photostimulation of neuronal and cardiac activity through efficient light‐to‐photocurrent conversion. These platforms provide a versatile approach for controlled bioelectrical modulation. In parallel, we demonstrate that graphene quantum dots exhibit strong antimicrobial activity via reactive oxygen species generation against multiple bacterial strains, offering an additional functional benefit for next‐generation biomedical implant technologies.
Zitieren
APA
Nizamoglu, S., Kaleli, H. N., Kaya, T. S., Ozelci, O. F., Hassnain, M., Yildiz, G., Oztopal, M., Caliskan, U. B., Onal, A., Tekinay, E., Yilmaz, A., & Khan, S. U. (2026). 71‐1: Quantum Dot Optoelectronics for Biomedical Implants. SID Symposium Digest of Technical Papers, 57(1), 979-982. https://doi.org/10.1002/sdtp.70001_267
Vancouver
Nizamoglu S, Kaleli HN, Kaya TS, Ozelci OF, Hassnain M, Yildiz G, et al. 71‐1: Quantum Dot Optoelectronics for Biomedical Implants. SID Symposium Digest of Technical Papers. 2026;57(1):979-982. doi:10.1002/sdtp.70001_267
BibTeX
@article{Nizamoglu2026,
author = {Nizamoglu, Sedat and Kaleli, Humeyra Nur and Kaya, Tarik Safa and Ozelci, Omer Faruk and Hassnain, Muhammad and Yildiz, Gizem and Oztopal, Melike and Caliskan, Ugur Berkay and Onal, Asım and Tekinay, Eren and Yilmaz, Alp and Khan, Saad Ullah},
title = {71‐1: Quantum Dot Optoelectronics for Biomedical Implants},
journal = {SID Symposium Digest of Technical Papers},
year = {2026},
volume = {57},
number = {1},
pages = {979--982},
doi = {10.1002/sdtp.70001_267}
}
EUVIMED